• Skip to primary navigation
  • Skip to main content
  • Skip to footer

American Infusion Services

  • Home Treatment
  • LTC Facilities
  • Evusheld
  • Jobs
  • Resources
  • Contact
  • Book Appointment
  • Home Treatment
  • LTC Facilities
  • Evusheld
  • Jobs
  • Resources
  • Contact
  • FAQs
  • Book Appointment
Smiling nurse

Monoclonal Antibody Therapy (mAb) for COVID-19

Check if you’re eligible for at-home mAbs


Monoclonal antibody treatment can reduce the risk of severe illness and hospitalization when you test positive for COVID-19. American Infusion’s skilled team offers mAb therapy in the convenience of your home or LTC facility.

locator

Currently servicing parts of:
New York, New Jersey, Pennsylvania, Maryland and Ohio

Find out more about mAbs for your facility

Contact Us

Emergency use

FDA-authorized

Monoclonal antibody therapy is for emergency use in individuals with high-risk COVID factors or in danger of developing severe illness.

Home Treatment

Convenient At-Home Treatment

We offer monoclonal antibody therapy and treatment systems direct to your home or long-term care facility, administered by American Infusion trained nursing staff.

Pocket Cost

No Out Pocket Cost

mAbs treatment is fully covered by insurance or federal uninsured funds, with zero out-of-pocket fees.

logo

How can we help you combat COVID-19?

nurse-icon

mAbs for At-Home Treatment

Protect yourself and your loved ones from severe illness and hospitalizations due to COVID-19. If you tested positive for COVID, you may be eligible for safe and effective mAb treatment in the convenience of your home.

Get Home Treatment

hospital icon

mAbs for Long-Term Care Facilities

Protect your residents from severe illness and hospitalization with mAb therapy. A resident who tests positive for COVID-19 is likely eligible for mAbs therapy treatment.

Get Treatment for Your LTC Facility

nurse posing with seniors

mAbs are administered directly after exposure to COVID-19 when you test positive, or up to 10 days after onset of symptoms.

70%-85% Reduction In Hospitalizations

Monoclonal antibody therapy reduces the chance of severe illness, hospitalization and patient fatalities.

80% Reduction In Spread

mAbs treatment reduces the spread of COVID-19 and infection among patients’ households.

We’re Hiring!

Nurses Apply Here
logo-without-type

Protect your family. Protect your residents.

Check if you’re eligible for at-home mAbs

Find out more about mAbs for your facility

Contact Us

Footer

carroll-county-logo
© Copyright 2022, American Infusion.
All rights reserved.

Contact Us

info@americaninfusion.com

1-855-AM-INFUSE

Quick Links

  • Home Treatment
  • LTC Facilities
  • Jobs
  • Resources
  • FAQs
  • Contact